Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for Alere Toxicology Services, Inc.�
40.57
-0.01 (-0.02%)
Jan 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 39.49 - 40.68
52 week 31.94 - 43.13
Open 40.68
Vol / Avg. 580,510.00/609,077.00
Mkt cap 3.39B
P/E     -
Div/yield     -
EPS -2.04
Shares 83.56M
Beta 1.92
Inst. own 92%
Feb 9, 2015
Q4 2014 Alere Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jan 12, 2015
Alere Inc at JPMorgan Healthcare Conference
Nov 20, 2014
Alere Inc at Jefferies Global Healthcare Conference - London
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -13.55% -2.90%
Operating margin 5.09% 4.44%
EBITD margin - 20.13%
Return on average assets -5.80% -1.24%
Return on average equity -28.87% -6.08%
Employees 17,600 -
CDP Score - -

Address

Suite 200, 51 Sawyer Road
WALTHAM, MA 02453
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alere Inc. is a provider of point-of-care diagnostics and services. The Company�s portfolio includes a range of health information solutions and provides clinical decision support. The Company operates in two segments: professional diagnostics and consumer diagnostics. The professional diagnostics segment includes a range of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions. The consumer diagnostics segment consists of manufacturing operations related to its role as the manufacturer of products for SPD Swiss Precision Diagnostics (SPD). Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology.

Officers and directors

Namal Nawana President, Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
David Teitel Chief Financial Officer, Vice President, Treasurer
Age: 50
Bio & Compensation  - Reuters
Daniella Cramp Global President - cardiometabolic business unit
Age: 40
Bio & Compensation  - Reuters
Hilde Eylenbosch M.D. President - Alere International Limited
Age: 50
Bio & Compensation  - Reuters
Craig Keyes M.D. Global President - Alere Health Information Solutions
Age: 58
Bio & Compensation  - Reuters
Sanjay Malkani Global President - Toxicology
Age: 44
Bio & Compensation  - Reuters
Avi Pelossof Global President - Infectious Disease
Bio & Compensation  - Reuters
Paul T. Hempel Senior Vice President - Ethics/Compliance, Special Counsel, Assistant Secretary
Age: 65
Bio & Compensation  - Reuters
John Bridgen Ph.D. Senior Vice President - Business Development
Age: 67
Bio & Compensation  - Reuters
Carla Flakne Chief Accounting Officer, Vice President
Age: 60
Bio & Compensation  - Reuters